Document Detail


Estimated morbidity and mortality in adolescents and young adults diagnosed with Type 2 diabetes mellitus.
MedLine Citation:
PMID:  22150528     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Aims:  To estimate remaining life expectancy, quality-adjusted life expectancy, causes of death and lifetime cumulative incidence of microvascular/macrovascular complications of diabetes for youths diagnosed with Type 2 diabetes. Methods:  A Markov-like computer model simulated the life course for a hypothetical cohort of adolescents/young adults in the USA, aged 15-24 years, newly diagnosed with Type 2 diabetes following either conventional or intensive treatment based on the UK Prospective Diabetes Study. Outcomes included remaining life expectancy, discounted quality-adjusted life expectancy in quality-adjusted life years, cumulative incidence of microvascular/macrovascular complications and causes of death. Results:  Compared with a mean remaining life expectancy of 58.6 years for a 20-year-old in the USA without diabetes, conventional treatment produced an average remaining life expectancy of 43.09 years and 22.44 discounted quality-adjusted life years. Intensive treatment afforded an incremental 0.98 years and 0.44 discounted quality-adjusted life years. Intensive treatment led to lower lifetime cumulative incidence of all microvascular complications and lower mortality from microvascular complications (e.g. end-stage renal disease death 19.4% vs. 25.2%). Approximately 5% with both treatments had end-stage renal disease within 25 years. Lifetime cumulative incidence of coronary heart disease increased with longer remaining life expectancy and greater severity of coronary heart disease risk factors. Incorporating disutility (loss in health-related quality of life) of intensive treatment resulted in net loss of quality adjusted life years.. Conclusions:  Adolescents/young adults with Type 2 diabetes lose approximately 15 years from average remaining life expectancy and may experience severe, chronic complications of Type 2 diabetes by their 40s. The net clinical benefit of intensive treatment may be sensitive to preferences for treatment. A comprehensive management plan that includes early and aggressive control of cardiovascular risk factors is likely needed to reduce lifetime risk of coronary heart disease. © 2011 The Authors. Diabetic Medicine© 2011 Diabetes UK.
Authors:
E T Rhodes; L A Prosser; T J Hoerger; T Lieu; D S Ludwig; L M Laffel
Related Documents :
10588478 - Taurine attenuates hypertension and improves insulin sensitivity in the fructose-fed ra...
3371178 - Effects of several simple sugars on serum glucose and serum fructose levels in normal a...
8786718 - Identification of galactitol 2-phosphate and galactitol 3-phosphate in the lens of gala...
21362008 - Type 2 diabetes: perceptions of quality of life and attitudes towards diabetes from a g...
2071608 - Forskolin photoaffinity labels with specificity for adenylyl cyclase and the glucose tr...
12827448 - The evolution of resource use.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-12-12
Journal Detail:
Title:  Diabetic medicine : a journal of the British Diabetic Association     Volume:  -     ISSN:  1464-5491     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8500858     Medline TA:  Diabet Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK.
Affiliation:
Division of Endocrinology, Children's Hospital Boston, Boston, MA Department of Pediatrics, Harvard Medical School, Boston, MA Child Health Evaluation and Research Unit, Division of General Pediatrics, University of Michigan, Ann Arbor, MI Center for Child Health Care Studies, Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA RTI-UNC Center of Excellence in Health Promotion Economics, RTI International, Research Triangle Park, NC Division of General Pediatrics, Children's Hospital Boston, Boston, MA Pediatric, Adolescent and Young Adult Section, Joslin Diabetes Center, Boston, MA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Activation of MU opioid receptors in the striatum differentially augments Methamphetamine-Induced ge...
Next Document:  Effects of load on the time course of attentional engagement, disengagement, and orienting in readin...